Noveris Health Sciences is trading at CA$0.08, up 14.29%, with no clear catalyst identified.
- The latest company release found was the September 9 annual-meeting update; no October 13 announcement is listed.
- Biotech sector weakness is not a clear explanation for the rise; available evidence does not establish a direct cause.
- The move therefore remains unexplained.